Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Long-Term Deferred Tax (2020 - 2025)

Cellebrite DI (CLBT) has 2 years of Long-Term Deferred Tax data on record, last reported at $12.5 million in Q4 2022.

  • For Q4 2022, Long-Term Deferred Tax rose 27.66% year-over-year to $12.5 million; the TTM value through Dec 2022 reached $12.5 million, up 27.66%, while the annual FY2022 figure was $12.5 million, 27.66% up from the prior year.
  • Long-Term Deferred Tax reached $12.5 million in Q4 2022 per CLBT's latest filing, up from $9.8 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $12.5 million in Q4 2022 and bottomed at $9.8 million in Q4 2021.